Total Payments
$8,880
2024 Payments
$2,345
Companies
31
Transactions
251
Medicare Patients
1,044
Medicare Billing
$54,432
Payment Breakdown by Category
Food & Beverage$7,581 (85.4%)
Travel$1,204 (13.6%)
Research$70.05 (0.8%)
Education$25.76 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,581 | 241 | 85.4% |
| Travel and Lodging | $1,204 | 6 | 13.6% |
| Unspecified | $70.05 | 1 | 0.8% |
| Education | $25.76 | 3 | 0.3% |
Payments by Type
General
$8,810
250 transactions
Research
$70.05
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $2,190 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,248 | 41 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $962.15 | 58 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $598.26 | 13 | $0 (2024) |
| HEARTFLOW, INC. | $545.27 | 5 | $0 (2024) |
| Abbott Laboratories | $522.24 | 5 | $0 (2023) |
| Amgen Inc. | $332.01 | 15 | $0 (2024) |
| PFIZER INC. | $325.97 | 20 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $322.73 | 13 | $0 (2024) |
| Edwards Lifesciences Corporation | $282.68 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,345 | 63 | AstraZeneca Pharmaceuticals LP ($400.39) |
| 2023 | $3,679 | 72 | Medtronic, Inc. ($1,887) |
| 2022 | $1,606 | 51 | Abbott Laboratories ($344.61) |
| 2021 | $1,251 | 65 | AstraZeneca Pharmaceuticals LP ($373.22) |
All Payment Transactions
251 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.64 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $34.67 | General |
| Category: Cardio-pulmonary | ||||||
| 12/06/2024 | Innovation Technologies Inc | IRRISEPT (Device) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: JET LAVAGE DEVICE WITH CHG | ||||||
| 12/03/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $136.67 | General |
| Category: Coronary | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $105.77 | General |
| Category: Renal Denervation System | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $49.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/18/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $38.48 | General |
| Category: Cardiology | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $116.87 | General |
| Category: Cardiovascular | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Rare Disease | ||||||
| 10/16/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Transcatheter Heart Valves | ||||||
| 10/08/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.79 | General |
| Category: Cardiovascular | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $8.57 | General |
| Category: Cardiovascular | ||||||
| 09/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Cardiology | ||||||
| 09/04/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $13.22 | General |
| Category: Endovascular | ||||||
| 08/30/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Rare Disease | ||||||
| 08/28/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $154.44 | General |
| Category: Coronary | ||||||
| 08/27/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $95.51 | General |
| 08/22/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $110.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $110.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: CARDIOVASCULAR | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PIV Patient Identification | ABIOMED | $70.05 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 423 | 457 | $71,378 | $27,843 |
| 2022 | 3 | 117 | 119 | $8,632 | $3,043 |
| 2021 | 6 | 142 | 145 | $16,041 | $5,272 |
| 2020 | 6 | 362 | 382 | $49,962 | $18,273 |
Total Patients
1,044
Total Services
1,103
Medicare Billing
$54,432
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 222 | 248 | $38,192 | $14,878 | 39.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 92 | $20,056 | $7,879 | 39.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 32 | 32 | $9,792 | $3,821 | 39.0% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 24 | 24 | $1,440 | $597.21 | 41.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 36 | 37 | $962.00 | $363.34 | 37.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 24 | 24 | $936.00 | $304.54 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 25 | $4,000 | $1,449 | 36.2% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2022 | 46 | 46 | $2,760 | $1,027 | 37.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2022 | 48 | 48 | $1,872 | $566.87 | 30.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 29 | 30 | $4,770 | $1,516 | 31.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 11 | $3,469 | $1,248 | 36.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 17 | $3,820 | $1,071 | 28.0% |
| 93017 | Exercise or drug-induced heart and blood vessel stress test with ekg tracing and monitoring | Office | 2021 | 36 | 37 | $2,220 | $878.05 | 39.6% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Office | 2021 | 35 | 36 | $1,404 | $467.79 | 33.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 14 | 14 | $358.00 | $91.44 | 25.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 105 | 117 | $22,113 | $8,092 | 36.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 135 | 141 | $18,048 | $6,512 | 36.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 21 | 22 | $5,610 | $2,216 | 39.5% |
| 93017 | Exercise or drug-induced heart and blood vessel stress test with ekg tracing and monitoring | Office | 2020 | 29 | 29 | $1,740 | $629.09 | 36.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 43 | 44 | $1,320 | $434.77 | 32.9% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Office | 2020 | 29 | 29 | $1,131 | $388.52 | 34.4% |
About Alla Havens, FNP-BC
Alla Havens, FNP-BC is a Family healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2017. The National Provider Identifier (NPI) number assigned to this provider is 1639615347.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alla Havens, FNP-BC has received a total of $8,880 in payments from pharmaceutical and medical device companies, with $2,345 received in 2024. These payments were reported across 251 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($7,581).
As a Medicare-enrolled provider, Havens has provided services to 1,044 Medicare beneficiaries, totaling 1,103 services with total Medicare billing of $54,432. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Fort Worth, TX
- Active Since 01/18/2017
- Last Updated 10/12/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1639615347
Products in Payments
- MICRA (Device) $1,849
- FARXIGA (Drug) $855.84
- LEQVIO (Drug) $555.54
- FFRct (Device) $545.27
- CAMZYOS (Drug) $542.01
- ENTRESTO (Drug) $406.61
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $344.61
- LifeVest (Device) $322.73
- Repatha (Biological) $317.28
- VERQUVO (Drug) $270.18
- ELIQUIS (Drug) $269.21
- Impella (Device) $213.15
- SAPIEN 3 Ultra RESILIA (Device) $200.38
- CARDIOMEMS (Device) $177.63
- ANDEXXA (Biological) $148.23
- CROME DR MRI SURESCAN (Device) $122.16
- AVVIGO Guidance System (Device) $119.85
- COREVALVE EVOLUT R (Device) $113.18
- VYNDAQEL (Drug) $113.01
- SYMPLICITY G3 (Device) $105.77
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Fort Worth
Laura Moe, Fnp, FNP
Family — Payments: $122,135
Family $122,135
Mrs. Julie Taylor, Ms-Fnp, MS-FNP
Family — Payments: $37,885
Family $37,885
Ryan Bourgeois, Fnp, FNP
Family — Payments: $20,320
Family $20,320
Rachel Stewart, Fnp, FNP
Family — Payments: $9,657
Family $9,657
Mrs. Dale Fuller, Fnp, FNP
Family — Payments: $8,948
Family $8,948
Jocelyn Urbano, Pmhnp, PMHNP
Family — Payments: $8,812
Family $8,812